If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
708.00    10.00 (1.43%)
Bid:
708.00
Ask:
709.00
Spread: 1.00 (0.141%)
Market Cap: £1.91b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Trading Update

1 Jul 2026 07:00

RNS Number : 4659K
CMC Markets Plc
01 July 2026
Β 

01 July 2026

Β 

CMC MARKETS PLC

("CMC" the "Group" or the "Company")

Β 

Trading update and upgrade to FY2027 NOI guidance

Β 

CMC Markets PLC today provides an update on trading for FY2027.

As outlined at our FY2026 results, the Group entered the new financial year with strong momentum driven by exponential and exceptional growth in our B2B business. That momentum has continued to build and scale.

As a result, CMC now expects net operating income for FY2027 to be at least Β£550 million, materially ahead of previous guidance of Β£460 million to Β£480 million, with EBITDA guidance of Β£250 million.

FY2027 guidance for operating expenses excluding variable remuneration of approximately Β£280 million remains unchanged.

The strength of this performance reflects the scale of our B2B platforms driving operational gearing and delivering higher profit margins as income growth is delivered against a largely fixed cost base.

Our B2B platform business is well positioned to scale with several important milestones expected over the next 12 months and a continuous pipeline of new B2B opportunities.

Operational gearing and investing for growth through B2B platforms, products, technology and partnerships continue to drive profit margins higher.

The Group's next scheduled update is at the HY2027 results on 19 November 2026.

Β 

Β 

Β 

Forthcoming announcement dates:

19 November 2026 HY2027 Interim Results

Β 

Enquiries

CMC Markets Plc

David Fineberg, Head of Strategic Partnerships

Matthew Lee, Investor Relations investor.relations@cmcmarkets.com

Β 

Notes to Editors

CMC Markets Plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The Company serves retail and institutional clients through regulated offices and branches in 12 countries with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade over 12,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, Singapore and the UK, access stockbroking services. More information is available atΒ http://www.cmcmarketsplc.com.

Β 

MAR disclosure statement

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTEAKKEDENKEFA
Date   Source Headline
9th Aug 202312:13 pmRNSDirector/PDMR Shareholding
9th Aug 202312:11 pmRNSDirector/PDMR Shareholding
9th Aug 202312:10 pmRNSDirector/PDMR Shareholding
8th Aug 202310:00 amRNSDirector/PDMR Shareholding
27th Jul 20233:27 pmRNSResult of AGM
27th Jul 20237:00 amRNSTrading Statement
21st Jul 202311:20 amRNSDirector/PDMR Shareholding
21st Jul 202310:07 amRNSDirector/PDMR Shareholding
12th Jul 202310:27 amRNSDirector/PDMR Shareholding
7th Jul 202310:09 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSDirectorate Change
23rd Jun 20235:09 pmRNSNotice of AGM
13th Jun 20237:00 amRNSFinal Results
9th Jun 20237:00 amRNSInvestment in StrikeX Technologies
6th Jun 20231:48 pmRNSDirector/PDMR Shareholding
9th May 20231:34 pmRNSDirector/PDMR Shareholding
6th Apr 20233:40 pmRNSDirector/PDMR Shareholding
31st Mar 202310:56 amRNSHolding(s) in Company
27th Mar 20233:51 pmRNSTrading Statement
7th Mar 20232:49 pmRNSDirector/PDMR Shareholding
7th Feb 202311:37 amRNSDirector/PDMR Shareholding
25th Jan 20237:00 amRNSTrading Statement
9th Jan 20232:15 pmRNSDirector/PDMR Shareholding
9th Jan 202312:50 pmRNSDirector/PDMR Shareholding
6th Jan 20233:22 pmRNSDirector/PDMR Shareholding
14th Dec 202212:38 pmRNSDirectorate Change
6th Dec 20222:38 pmRNSDirector/PDMR Shareholding
21st Nov 20221:54 pmEQSCMC Markets 'to continue rolling out investment platform'
16th Nov 20227:00 amRNSInterim Results
7th Nov 20223:25 pmRNSDirector/PDMR Shareholding
1st Nov 202210:28 amRNSTotal Voting Rights
17th Oct 20225:50 pmRNSTransaction in Own Shares
14th Oct 20225:25 pmRNSTransaction in Own Shares
13th Oct 20225:39 pmRNSTransaction in Own Shares
12th Oct 20225:11 pmRNSTransaction in Own Shares
11th Oct 20225:16 pmRNSTransaction in Own Shares
10th Oct 20225:41 pmRNSTransaction in Own Shares
7th Oct 20225:46 pmRNSTransaction in Own Shares
6th Oct 20225:16 pmRNSTransaction in Own Shares
6th Oct 202212:49 pmRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSTrading Update
4th Oct 20225:25 pmRNSTransaction in Own Shares
3rd Oct 20225:18 pmRNSTransaction in Own Shares
3rd Oct 202210:58 amRNSTotal Voting Rights
30th Sep 20225:31 pmRNSTransaction in Own Shares
29th Sep 20225:15 pmRNSTransaction in Own Shares
29th Sep 20223:07 pmRNSDirector Declaration
28th Sep 20225:19 pmRNSTransaction in Own Shares
27th Sep 20225:28 pmRNSTransaction in Own Shares
26th Sep 20225:28 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.